These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Premature with trichomoniasis: report of one case. Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336 [TBL] [Abstract][Full Text] [Related]
5. [Antitrichomonal properties of an antiseptic drug cidizol-KB]. Kravchenko VG; Vasil'ev MM Vestn Dermatol Venerol; 1984 Dec; (12):31-2. PubMed ID: 6335801 [No Abstract] [Full Text] [Related]
6. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365 [TBL] [Abstract][Full Text] [Related]
7. Experimental models for the evaluation of systemic trichomonacides. Models for evaluation of trichomonacides. Tsai YH; Price KE Chemotherapy; 1973; 18(6):348-57. PubMed ID: 4542601 [No Abstract] [Full Text] [Related]
8. [Comparative effectiveness of chlomizel and methronidazole in the treatment of men with trichomonas infections]. Potapnev FV Urol Nefrol (Mosk); 1971; 36(4):57-60. PubMed ID: 5148837 [No Abstract] [Full Text] [Related]
9. [Trichomonas vaginalis infection in the male]. Haschek H; Kofler K Med Klin; 1973 Jan; 68(4):106-10. PubMed ID: 4567799 [No Abstract] [Full Text] [Related]
10. [A comparative study of nitrimidazine and metronidazole in the treatment of trichomonas infections]. Goldman JA Harefuah; 1974 May; 86(9):463-5. PubMed ID: 4839423 [No Abstract] [Full Text] [Related]
12. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis. Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672 [TBL] [Abstract][Full Text] [Related]
13. Trichomonal epididymitis. Breier M; Gyarmathy F Ther Hung; 1971; 19(2):64-6. PubMed ID: 5317463 [No Abstract] [Full Text] [Related]
14. Why is Trichomonas vaginalis ignored? Bowden FJ; Garnett GP Sex Transm Infect; 1999 Dec; 75(6):372-4. PubMed ID: 10754936 [No Abstract] [Full Text] [Related]
15. National guideline for the management of Trichomonas vaginalis. Clinical Effectiveness Group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect; 1999 Aug; 75 Suppl 1():S21-3. PubMed ID: 10616377 [No Abstract] [Full Text] [Related]
16. Mind the gap: bridging the divide between clinical and molecular studies of the trichomonads. Lyons EJ; Carlton JM Trends Parasitol; 2004 May; 20(5):204-7. PubMed ID: 15105016 [No Abstract] [Full Text] [Related]
17. What is the best way to treat trichomoniasis in women? Epling J Am Fam Physician; 2001 Oct; 64(7):1241-2, 1244. PubMed ID: 11601807 [No Abstract] [Full Text] [Related]
18. Trichomoniasis. An update on diagnostic tools and treatments. Reyes M Adv Nurse Pract; 2008 Apr; 16(4):69-70, 72. PubMed ID: 19999494 [No Abstract] [Full Text] [Related]
19. [Comparative evaluation of the effectiveness of chlomisole, flagyl and trichopole in treating trichomoniasis in women]. Turanova EN; Potapnev FV; Iatsukha MV Vestn Dermatol Venerol; 1971 Aug; 45(8):51-5. PubMed ID: 5136374 [No Abstract] [Full Text] [Related]